NFL Hall of Famer Brett Favre Has Parkinson's Disease
By Ernie Mundell HealthDay Reporter
TUESDAY, Sept. 24, 2024 -- Green Bay Packers legend and NFL Hall of Famer Brett Favre announced Tuesday that he has been diagnosed with Parkinson's disease.
Favre, 54, made the announcement while testifying to Congress on his potential misuse of taxpayer funds.
The former quarterback has been presenting testimony in Washington to the House Ways and Means Committee, following accusations that he used political connections to funnel public money to himself and his alma mater, the University of Southern Mississippi.
As reported by NBC News, Favre told assembled lawmakers that, "Sadly, I also lost an investment in a company that I believed was developing a breakthrough concussion drug I thought would help others, and I’m sure you’ll understand why it’s too late for me because I’ve recently been diagnosed with Parkinson’s."
Frequent head injuries could be a risk factor for Parkinson's. One study published last year found that people with a history of playing football were 61% more likely to be diagnosed with the brain illness.
According to the Parkinson's Foundation, Parkinson's is an incurable, degenerative brain disease with symptoms developing over a period of years. Not everyone will experience the same symptoms, but they can include tremor, slowness and other difficulties in walking and limb stiffness.
Cognitive impairments, sleep issues, depression, apathy, anxiety, constipation, falling upon standing and other issues can also arise.
Medicines such as dopamine-replacing drugs can help curb symptoms and slow the illness, but they are not a cure.
Other well-known Americans affected by Parkinson's disease include Michael J. Fox, singer Linda Ronstadt, actor Alan Alda and rock musician Ozzy Osbourne.
Favre's health revelation came amid allegations that he improperly used money from the federal Temporary Assistance for Needy Families (TANF) program. He has not been criminally charged, but is repaying some of the money, NBC News reported.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-09-25 06:00
Read more
- FDA Approves Ryoncil (remestemcel-L-rknd) Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft Versus Host Disease
- SABCS: Chest Wall Irradiation Does Not Impact Survival in Breast Cancer
- U.S. Adult Obesity Rate Fell in 2023, as Use of GLP-1 Meds Rose
- Global Warming's Heat Is Killing the World's Young
- FDA Approves Crenessity (crinecerfont) for the Treatment of Children and Adults with Classic Congenital Adrenal Hyperplasia
- Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory Waldenstrom’s Macroglobulinemia
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions